SG3 Management’s NEOPHOTONICS CORP NPTN Stock Holding History

SG3 Management’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-48,900	Closed	-$298K	–	407
2019 Q3	$298K	Buy	+48,900	New	+$275K	0.03%	222

Other funds holding NPTN

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

SG3 Management's NPTN Position: Q3 2019 in Review

SG3 Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2019, closing a stake of 600 shares — an estimated $3.37K sold.

SG3 Management first reported a position in NPTN in Q2 2019 and held it in 1 quarter. The position peaked at $3K in Q2 2019. 116 funds tracked by Wall St. Rank hold NPTN as of Q3 2019.

SG3 Management reported no remaining NEOPHOTONICS CORP position as of Q3 2019 after selling out during the quarter.
SG3 Management sold 600 NEOPHOTONICS CORP shares in Q3 2019, an estimated $3.37K.
SG3 Management first reported a position in NEOPHOTONICS CORP in Q2 2019 and held it in 1 quarter.
SG3 Management's NEOPHOTONICS CORP position peaked at $3K in Q2 2019.
116 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2019.

Based on SG3 Management's 13F filing for Q3 2019, filed 13 Nov 2019.